PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC)

Autor:	Frederic Peyrade, Christophe Le Tourneau, Jérôme Fayette, Joël Guigay, Laura Faivre, J. Delaye, Didier Cupissol, Laurence Digue, Brigitte Laguerre, François Bidault, Christian Borel, Caroline Even, Laurence Bozec Le Moal, Sylvie Zanetta, Frederic Rolland, Anne Auperin, Valérie Costes, Pascal Do
Rok vydání:	2016
Předmět:	0301 basic medicine Cancer Research medicine.medical_specialty Adenoid cystic carcinoma Phases of clinical research behavioral disciplines and activities Gastroenterology Pazopanib 03 medical and health sciences 0302 clinical medicine Internal medicine otorhinolaryngologic diseases medicine In patient Head and neck business.industry medicine.disease Salivary gland carcinoma stomatognathic diseases 030104 developmental biology nervous system Oncology 030220 oncology & carcinogenesis business psychological phenomena and processes medicine.drug
Zdroj:	Journal of Clinical Oncology. 34:6086-6086
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.6086
Popis:	6086Background: SGC of head and neck (SGCHN) are rare tumors including adenoid cystic carcinoma (ACC) and non-ACC, with no standard systemic treatment for R/M patients (pts). Pazopanib (Pb) is an o...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d8ef0a4f1313ffbb39b28ec1ae0197e4 https://doi.org/10.1200/jco.2016.34.15_suppl.6086 Zobrazit plný text záznamu